Wang Yu


Wang Yu specialises in U.S. capital markets with more than 10 years of experience advising on securities offerings, private equity deals and other corporate transactions.  He represents corporate clients, investment banks and private equity funds on transactional matters including capital markets, private equity and financial derivative products.

In 2018, Mr. Wang was recognised for his expertise in Capital Markets (Equity) in Hong Kong by Legal 500 Asia Pacific.  Prior to joining KWM, he worked in leading U.S. international law firms in New York, Beijing and Hong Kong.  He is fluent in Mandarin and English.

Relevant Experience

  • Representing issuers and sponsors for a number of listing applications on the Hong Kong Stock Exchange of biotech companies under Listing Rules Chapter 18A.*
  • Represented Haitong International Capital Limited on Genescript Biotech Corporation’s initial public offering on the Hong Kong Stock Exchange. *
  • Represented Shanghai Dazhong Public Utilities (Group) Co., Ltd. in its initial public offering on the Hong Kong Stock Exchange. *
  • Represented Phoenix New Media Limited in its initial public offering on the New York Stock Exchange. *
  • Represented Covanta Holding Corp. in its call spread transaction in connection with its US$400 million convertible notes offering.*
  • Represented Catalent Pharma Solutions Inc. in its Interests Rate Swap transactions. *
  • Represented Blackstone Finance Holdings Co. in its Interest Rate Swap and FX transactions. *
  • Represented Oversea Shipping Group, Inc. in its tender offer. *
  • Proposed acquisition by a private equity firm in the green energy industry in the U.S. *
  • Proposed strategic acquisition in the energy industry by Blackstone Group. *

*Transactions Mr. Wang completed prior to joining KWM.


Legal insights

This article provides an overview of the SPAC structure and its key features in the U.S. and Singapore.

28 September 2021

We discuss the proposed measures in the recent consultation paper issued by the SFC.

09 February 2021

We sum up the definitions of accredited investor and qualified institutional buyer as proposed by the U.S. Securities and Exchange Commission.

10 September 2020

This site uses cookies to enhance your experience and to help us improve the site. Please see our Privacy Policy for further information. If you continue without changing your settings, we will assume that you are happy to receive these cookies. You can change your cookie settings at any time.

For more information on which cookies we use then please refer to our Cookie Policy.